NDT Pharmaceuticals (OTCPK:NDTP) - Stock Price, News & Analysis

NDTP Stock Overview

A biotechnology company, focuses on developing various therapies for severe neurological disorders associated with traumatic brain Injury. More details

NDTP fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

Does not have a meaningful market cap ($25K)

Shares are highly illiquid

NDT Pharmaceuticals Inc. Competitors

Hero Technologies

OTCPK:HENC

US$563.0

CBD Life Sciences

OTCPK:CBDL

US$1.4m

Lucy Scientific Discovery

OTCPK:LSDI.F

US$8.8k

Veritas Farms

OTCPK:VFRM

US$81.9k

Price History & Performance

Summary of all time highs, changes and price drops for NDT Pharmaceuticals
Historical stock prices
Current Share Price	US$0.053
52 Week High	US$0.67
52 Week Low	US$0.022
Beta	0
11 Month Change	-32.66%
3 Month Change	-80.94%
1 Year Change	-55.83%
33 Year Change	-62.14%
5 Year Change	-98.34%
Change since IPO	-99.92%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	NDTP	US Pharmaceuticals	US Market
7D	-10.8%	2.6%	0.5%
1Y	-55.8%	13.1%	30.7%

Return vs Industry: NDTP underperformed the US Pharmaceuticals industry which returned 13.1% over the past year.

Return vs Market: NDTP underperformed the US Market which returned 30.7% over the past year.

Price Volatility

Is NDTP's price volatile compared to industry and market?
NDTP volatility
NDTP Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	9.9%
Market Average Movement	6.3%
10% most volatile stocks in US Market	16.3%
10% least volatile stocks in US Market	3.1%

Stable Share Price: NDTP's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine NDTP's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2007	n/a	Jim Hovis	www.ndtpharma.com

NDT Pharmaceuticals Inc., a biotechnology company, focuses on developing various therapies for severe neurological disorders associated with traumatic brain Injury. The company is based in Vienna, Virginia.

NDT Pharmaceuticals Inc. Fundamentals Summary

How do NDT Pharmaceuticals's earnings and revenue compare to its market cap?
NDTP fundamental statistics
Market cap	US$25.28k
Earnings (TTM)	US$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is NDTP overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NDTP income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$0
Earnings	US$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did NDTP perform over the long term?

See historical performance and comparison